Insys Therapeutics (NASDAQ:INSY) is back in the news this week, after agreeing last Friday to pay a $225 million settlement to resolve criminal investigations regarding its role in marketing opioids, an addictive painkiller. This week, we’ve seen INSY close at a record low after th...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.